Nodal Involvement Pattern in Clinical Stage IA Non-Small Cell Lung Cancer According to Tumor Location

Nodal Involvement Pattern in Clinical Stage IA Non-Small Cell Lung Cancer According to Tumor Location

Shushi Meng, Ganwei Liu, Shaodong Wang, Fan Yang, Jun Wang Department of Thoracic Surgery, Peking University People’s Hospital, Beijing, People’s Republic of ChinaCorrespondence: Shaodong Wang; Jun WangDepartment of Thoracic Surgery, Peking University People’s Hospital,...

Full description

Bibliographic Details
Main Authors:	Meng S, Liu G, Wang S, Yang F, Wang J
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-08-01
Series:	Cancer Management and Research
Subjects:	non-small cell lung cancer clinical stage ⅰa lymph node dissection nodal involvement pattern
Online Access:	https://www.dovepress.com/nodal-involvement-pattern-in-clinical-stage-ia-non-small-cell-lung-can-peer-reviewed-article-CMAR

Similar Items

Difference in Frequency and Distribution of Nodal Metastases Between Intermediate and High Risk Prostate Cancer Patients: Results of a Superextended Pelvic Lymph Node Dissection
by: Marco Roscigno, et al.
Published: (2018-09-01)

Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid NSCLC: A Multi-Institutional Study
by: Donglai Chen, MD, et al.
Published: (2020-09-01)

Retrospective Study on Lobe-specific Lymph Node Dissection for Patients  with Early-stage Non-small Cell Lung Cancer
by: Jian CHEN, et al.
Published: (2012-09-01)

Feasibility of nodal classification for non‐small cell lung cancer by merging current N categories with the number of involved lymph node stations
by: Wei Chen, et al.
Published: (2019-07-01)

Nodal skip metastasis in thoracic esophageal squamous cell carcinoma: a cohort study
by: Francesco Cavallin, et al.
Published: (2017-05-01)

Is lobe specific lymph node dissection adequate for cN0–1 non-small cell lung cancer?
by: Likui Fang, et al.
Published: (2020-02-01)

Strategies of Lymph Node Dissection During Sublobar Resection for Early-Stage Lung Cancer
by: Dominique Gossot, et al.
Published: (2021-09-01)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
by: Yijun Wu, et al.
Published: (2020-09-01)

The Role of Lymph Node Dissection in the Treatment of Bladder Cancer
by: Francesco Cattaneo, et al.
Published: (2018-10-01)

SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE
by: E. O. Mantsyrev, et al.
Published: (2017-02-01)

Advances in Lymph Node Metastasis and the Modes of Lymph Node  Dissection in Early Stage Non-small Cell Lung Caner
by: Ningning DING, et al.
Published: (2016-06-01)

Advances of Mediastinal Lymph Node Metastasis and the Extent of Lymph Node  Dissection in Patients with Stage T1 Non-small Cell Lung Cancer
by: Ningning DING, et al.
Published: (2015-01-01)

New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non‐small cell lung cancer
by: Jiaqi Zhang, et al.
Published: (2019-12-01)

Pathological nodal staging score for rectal cancer patients treated with radical surgery with or without neoadjuvant therapy: a postoperative decision tool
by: Dai W, et al.
Published: (2019-01-01)

Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database
by: Liang Wu, et al.
Published: (2021-07-01)

Clinical significance of intrapulmonary lymph node dissection in pathological stage IA non‐small cell lung cancer: A propensity score matching analysis
by: Yungang Sun, et al.
Published: (2021-05-01)

Intrapulmonary lymph node metastasis is common in clinically staged IA adenocarcinoma of the lung
by: DengGuo Zhang, et al.
Published: (2019-02-01)

Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA–IIA non-small cell lung cancer, a retrospective cohort study
by: Wenyu Zhai, et al.
Published: (2020-09-01)

Tumor Size Still Impacts Prognosis in Breast Cancer With Extensive Nodal Involvement
by: Yin Liu, et al.
Published: (2021-04-01)

Comparison of PET/CT with Invasive Staging and Pathological Staging of Lung Cancer; Analysis of 240 Cases
by: Kadir Burak Özer, et al.
Published: (2018-05-01)

Assessment of non‐lobe‐specific lymph node metastasis in clinical stage IA non‐small cell lung cancer
by: Zhirong Zhang, et al.
Published: (2019-07-01)

Extra Nodal (Cutaneous) Rosai Dorfman Disease
by: Talha Ahmed, et al.
Published: (2020-09-01)

Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancer
by: Shimokawa Hidehiko, et al.
Published: (2011-10-01)

Stage change from clinical N0 to pathological N+ neck: A retrospective analysis of 169 patients
by: Digpal Dharkar, et al.
Published: (2016-01-01)

New paradigm for stage III melanoma: from surgery to adjuvant treatment
by: Paolo Antonio Ascierto, et al.
Published: (2019-08-01)

Management options for stage 1 nonseminomatous germ cell tumors of the testis
by: Stephen D.W Beck
Published: (2010-01-01)

Role of clinical and morphological data in prediction of regional lymph node involvement in early-stage breast cancer
by: Yu. S. Shatova, et al.
Published: (2019-07-01)

Patients’ Preferences Regarding Invasive Mediastinal Nodal Staging of Resectable Lung Cancer
by: Bousema JE, et al.
Published: (2021-09-01)

Most frequent location of the sentinel lymph nodes
by: Chiao Lo, et al.
Published: (2014-07-01)

Evaluation of lymph node ratio and morphologic patterns of nodal reactive hyperplasia in primary organ malignancy
by: Shinde V Sweety, et al.
Published: (2019-01-01)

Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database
by: Liang Pan, et al.
Published: (2020-08-01)

Stage III melanoma: role of lymph node dissection and (neo-)adjuvant systemic therapies
by: van Akkooi, A.C.J, et al.
Published: (2022)

Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis
by: Awrad Nasralla, et al.
Published: (2020-10-01)

Association between number of dissected lymph nodes and survival in stage IA non-small cell lung cancer: a propensity score matching analysis
by: Lei-Lei Wu, et al.
Published: (2020-12-01)

CT-Guided Pelvic Lymph Nodal Brachytherapy
by: Hiroaki Kunogi, et al.
Published: (2021-02-01)

18F‐fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node‐negative non‐small cell lung cancer
by: Yusuke Takahashi, et al.
Published: (2019-03-01)

Nodal staging score and adequacy of nodal staging
by: Chen H, et al.
Published: (2019-01-01)

The Presence of Anti-p53 Antibodies in Sera Prior to Thoracic Surgery in Non Small Cell Lung Cancer Patients: Its Implications on Tumor Volume, Nodal Involvement, and Survival
by: Michael Bergqvist, et al.
Published: (2003-07-01)

Mediastinal lymph node dissection effectiveness in patients with I stage of non-small cell lung cancer
by: A. P. Kolesnik
Published: (2014-12-01)

Utilization Patterns of Lymph Node Dissection in Endometrial Cancer Patients Without Distant Metastasis in the United States
by: Alyea, Jennifer Marie
Published: (2021)